Chronic News and Research

RSS

Researchers uncover new lead for mechanism of action of frontline Type 2 diabetes drug

Canadian and British researchers have discovered how the frontline Type 2 diabetes drug metformin may work to help cells better take up and use glucose.

24 Oct 2018

Nerve-on-a-chip platform could help improve neuroprosthetic designs

Neuroprosthetics - implants containing multi-contact electrodes that can substitute certain nerve functionalities - have the potential to work wonders.

23 Oct 2018

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

The trillions of bacteria in the human gut affect our health in multiple ways including effects on immune functions and metabolism.

23 Oct 2018

Lowering systolic blood pressure does not damage the kidneys, shows study

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself.

23 Oct 2018

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

MWH Medical Pte Ltd, a leading homegrown medical group, and Siemens Healthineers are pleased to announce the launch of the first Asia Reference Center through their partnership.

From Siemens Healthineers 23 Oct 2018

Coaching improves medication adherence in people with diabetes, hypertension, high cholesterol

Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, will release data showing its telephonic health coaching program helped patients managing diabetes, hypertension and high cholesterol achieve a higher rate of adherence than patients without coaching.

23 Oct 2018

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.

23 Oct 2018

Volunteering for peer counseling programs benefits people with lupus

Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.

23 Oct 2018

Primary care doctors ‘not doing enough’ to curb STDs

Julie Lopez, 21, has been tested regularly for sexually transmitted diseases since she was a teenager. But when Lopez first asked her primary care doctor about screening, he reacted with surprise, she said.

22 Oct 2018

At-home biofeedback therapy effective in relieving difficult-to-treat constipation

Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

22 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis

Vertex Pharmaceuticals (Europe) Limited today announces that the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion for KALYDECO (ivacaftor) to include the treatment of people with cystic fibrosis (CF) aged 12 to <24 months who have at least one of the following nine mutations in their cystic fibrosis transmembrane conductance regulator gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R.

22 Oct 2018

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.

22 Oct 2018

Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus

A bioelectronic medicine device was effective in reducing pain and fatigue in patients with lupus, according to Feinstein Institute for Medical Research Professor Cynthia Aranow, MD, who will present pilot clinical trial results Tuesday at the American College of Rheumatology/Association of Rheumatology Professional's Annual Meeting.

22 Oct 2018

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents.

22 Oct 2018

Finnish study finds significant regional differences in endoscopic sinus surgery

Chronic rhinosinusitis is a common disease that is usually treated with intranasal medication and nasal saline lavage. Endoscopic sinus surgery) is considered when CRS is difficult to treat. The surgery aims to restore ventilation of paranasal sinuses and reduce inflammation.

22 Oct 2018

Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010

Air pollution in the U.S. has decreased since about 1990, and a new study conducted at the University of North Carolina at Chapel Hill now shows that this air quality improvement has brought substantial public health benefits.

20 Oct 2018

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

While it is widely shown that possessing the ApoE4 gene is the major genetic risk factor of Alzheimer's disease, not all ApoE4 carriers develop AD.

20 Oct 2018

IU researchers receive $1.55 million from NIH to improve chronic-disease management

The National Institutes of Health, under the National Library of Medicine's program on data science research, has awarded $1.55 million to an interdisciplinary team lead by Luis Rocha, a professor of informatics and the director of the NSF-NRT complex networks and systems program at the Indiana University School of Informatics, Computing and Engineering.

20 Oct 2018

Green leafy vegetables could help reduce macular degeneration risk

A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration.

19 Oct 2018

Chronic News and Research

Researchers uncover new lead for mechanism of action of frontline Type 2 diabetes drug

Nerve-on-a-chip platform could help improve neuroprosthetic designs

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

Lowering systolic blood pressure does not damage the kidneys, shows study

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

Coaching improves medication adherence in people with diabetes, hypertension, high cholesterol

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

Volunteering for peer counseling programs benefits people with lupus

Primary care doctors ‘not doing enough’ to curb STDs

At-home biofeedback therapy effective in relieving difficult-to-treat constipation

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis

Immune therapy may be potential treatment option for patients with hard-to-treat ankylosing spondylitis

Pilot clinical trial shows effectiveness of bioelectronic medicine device for lupus

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Finnish study finds significant regional differences in endoscopic sinus surgery

Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010

ApoE4 gene linked with chronic inflammation increases risk for Alzheimer's disease

IU researchers receive $1.55 million from NIH to improve chronic-disease management

Green leafy vegetables could help reduce macular degeneration risk

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News